Kenneth Kashkin

Kenneth Kashkin

Chairman bei EVOME MEDICAL TECHNOLOGIES INC.

Vermögen: 12 817 $ am 31.03.2024

73 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Kenneth B.
Kashkin
is the founder of K2 Biotechnology Ventures LLC, which was founded in 2017.
He is currently the Chairman at Evome Medical Technologies, Inc. since 2020.
Dr. Kashkin previously worked as the President & CEO-Institute Research & Innovation at CommonSpirit Health (Illinois) from 2011 to 2014.
He also held positions at Bayer AG as an Associate Director-Central Nervous System, Nova Pharmaceutical Corp.
as a Medical Director, Abbott Laboratories as a Principal, Baxter Healthcare Corp.
as the Vice President-Research & Development, Genaissance Pharmaceuticals, Inc. as the Chief Medical Officer & Executive Vice President, Yale University as a Professor, Ferring Pharmaceuticals, Inc. as the Chief Medical Officer & VP-Clinical Research, Knoll Pharmaceutical Co. as the Vice President-Clinical Development, Chromocell Corp.
as the Chief Operating Officer & Head-Therapeutics from 2013 to 2020, and at David Geffen School of Medicine and Yale School of Medicine as a Professor.
Dr. Kashkin obtained his undergraduate and doctorate degrees from the University of California, Los Angeles.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
07.07.2023 47 470 ( 0,08% ) 12 817 $ 31.03.2024

Aktive Positionen von Kenneth Kashkin

Ehemalige bekannte Positionen von Kenneth Kashkin

UnternehmenPositionEnde
Chief Operating Officer 01.01.2020
Corporate Officer/Principal 01.01.2014
Corporate Officer/Principal 01.01.2011
Knoll Pharmaceutical Co. Corporate Officer/Principal 01.01.2000
ABBOTT LABORATORIES Corporate Officer/Principal 01.01.1997
Sehen Sie sich die Erfahrung von Kenneth Kashkin im Detail an

Ausbildung von Kenneth Kashkin

University of California, Los Angeles Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Kenneth Kashkin im Detail an

Beziehungen

97

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
ABBOTT LABORATORIES

Health Technology

BAYER AG

Health Technology

EVOME MEDICAL TECHNOLOGIES INC.

Health Technology

Private Unternehmen8

Health Technology

Health Technology

Commercial Services

Health Technology

Knoll Pharmaceutical Co.

Nova Pharmaceutical Corp.

Commercial Services

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Kenneth Kashkin